China SXT Pharmaceuticals Inc. has entered into a securities purchase agreement to issue 200,000 Ordinary Shares, generating approximately $100,000 in gross proceeds. The offering, which closed on May 12, 2025, brings the total number of issued and outstanding Ordinary Shares to 16,027,758. The shares were issued under a prospectus supplement filed with the SEC, as part of a takedown from the company's shelf registration statement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-042394), on May 13, 2025, and is solely responsible for the information contained therein.